UK markets open in 7 hours 4 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.22 +0.27 (+0.34%) GOLD FUTURES
2,312.30 +2.70 (+0.12%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,154.14 +752.67 (+1.62%)
Everest Medicines Limited (1952.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 7.81B |
| Enterprise value | 5.82B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 56.26 |
| Price/book (mrq) | 1.45 |
| Enterprise value/revenue | 46.23 |
| Enterprise value/EBITDA | -7.82 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.16 |
| 52-week change 3 | 75.14% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 32.200 |
| 52-week low 3 | 10.320 |
| 50-day moving average 3 | 23.844 |
| 200-day moving average 3 | 21.613 |
Share statistics
| Avg vol (3-month) 3 | 4.7M |
| Avg vol (10-day) 3 | 3.36M |
| Shares outstanding 5 | 319.36M |
| Implied shares outstanding 6 | 319.36M |
| Float 8 | 184.22M |
| % held by insiders 1 | 0.43% |
| % held by institutions 1 | 49.44% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -361.83% |
Management effectiveness
| Return on assets (ttm) | -8.59% |
| Return on equity (ttm) | -15.90% |
Income statement
| Revenue (ttm) | 125.93M |
| Revenue per share (ttm) | 0.40 |
| Quarterly revenue growth (yoy) | 896.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -804.84M |
| Net income avi to common (ttm) | -844.46M |
| Diluted EPS (ttm) | -2.920 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.35B |
| Total cash per share (mrq) | 7.36 |
| Total debt (mrq) | 539.24M |
| Total debt/equity (mrq) | 10.85% |
| Current ratio (mrq) | 8.35 |
| Book value per share (mrq) | 15.56 |
Cash flow statement
| Operating cash flow (ttm) | -769.19M |
| Levered free cash flow (ttm) | 2.37B |
© 2024 Yahoo. All rights reserved.